Skip to content
Clinical Trials – home

Instituto de Investigacion Sanitaria Fundacion para la Investigacion del Hospital Clinico de Valencia-INCLIVA

Verifiedinfo

Spain Avenida Menendez Y Pelayo 4, 46010 Valencia, Spain

  • 8 trials recruiting
  • Colorectal cancer stage II · Colorectal cancer stage III · Pancreatitis acute
  • Adults and children

About Specializations

Instituto de Investigacion Sanitaria Fundacion para la Investigacion del Hospital Clinico de Valencia-INCLIVA in Valencia, Spain specialises in clinical trials of conditions such as Colorectal cancer stage II, Colorectal cancer stage III, Pancreatitis acute, Arteriosclerosis, and other specialisations. This site conducts important research.

Main research areas of the site

Analytical, Diagnostic and Therapeutic Techniques and Equipment

At Instituto de Investigacion Sanitaria Fundacion para la Investigacion del Hospital Clinico de Valencia-INCLIVA, research in this area focuses on therapeutic techniques and supportive care approaches for kidney disease and refractory heart failure. The trials are designed to better understand how treatments may improve fluid balance and sodium handling in patients with complex chronic conditions.

  • Improving diuresis and natriuresis in chronic kidney disease
  • Evaluating sodium removal through peritoneal dialysis
  • Assessing treatment strategies for refractory heart failure

This work reflects a practical focus on optimizing everyday clinical management for patients who need better control of fluid overload and related symptoms.

Diseases - Neoplasms

The oncology research at this Valencia site includes studies in neoplasms, especially cancers with microsatellite instability-high or mismatch repair deficiency. These trials aim to test new treatment options and explore how targeted therapies may help patients with advanced solid tumors that are difficult to treat.

  • Studying MSIhi and dMMR advanced solid tumors
  • Exploring novel cancer therapy options alone or in combination
  • Supporting treatment development for metastatic and unresectable cancer

The research is centered on improving outcomes for patients whose tumors carry specific DNA alterations and may respond differently to standard care.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Avenida Menendez Y Pelayo 446010 ValenciaSpain
Recruiting now
8 trials
Conditions studied
25
Partner status
Verified

More sites in ValenciaSpain

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

20 clinical trials

Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Shanghai Henlius Biotech Inc.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Zongertinib
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Eikon Therapeutics Inc.
Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Levofolinate
  • Sponsor:Ifom Istituto Fondazione Di Oncologia Molecolare Ets In Breve Ifom Ets
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVA
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Potassium Chloride
  • Sponsor:Hospital General Universitario Dr. Balmis
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Budigalimab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.